- Home
- PCVX vs MSGS Comparison
PCVX vs MSGS Comparison
Compare PCVX & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- MSGS
- Stock Information
- Founded
- PCVX 2013
- MSGS 1879
- Country
- PCVX United States
- MSGS United States
- Employees
- PCVX N/A
- MSGS N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- MSGS Services-Misc. Amusement & Recreation
- Sector
- PCVX Health Care
- MSGS Consumer Discretionary
- Exchange
- PCVX Nasdaq
- MSGS Nasdaq
- Market Cap
- PCVX 6.0B
- MSGS 5.3B
- IPO Year
- PCVX 2020
- MSGS N/A
- Fundamental
- Price
- PCVX $49.03
- MSGS $216.08
- Analyst Decision
- PCVX Strong Buy
- MSGS Buy
- Analyst Count
- PCVX 7
- MSGS 7
- Target Price
- PCVX $101.67
- MSGS $260.50
- AVG Volume (30 Days)
- PCVX 1.3M
- MSGS 176.7K
- Earning Date
- PCVX 11-04-2025
- MSGS 10-31-2025
- Dividend Yield
- PCVX N/A
- MSGS N/A
- EPS Growth
- PCVX N/A
- MSGS N/A
- EPS
- PCVX N/A
- MSGS N/A
- Revenue
- PCVX N/A
- MSGS $1,025,367,000.00
- Revenue This Year
- PCVX N/A
- MSGS N/A
- Revenue Next Year
- PCVX N/A
- MSGS $4.61
- P/E Ratio
- PCVX N/A
- MSGS N/A
- Revenue Growth
- PCVX N/A
- MSGS N/A
- 52 Week Low
- PCVX $27.66
- MSGS $173.26
- 52 Week High
- PCVX $98.17
- MSGS $237.99
- Technical
- Relative Strength Index (RSI)
- PCVX 69.14
- MSGS 44.32
- Support Level
- PCVX $40.14
- MSGS $218.09
- Resistance Level
- PCVX $45.90
- MSGS $224.84
- Average True Range (ATR)
- PCVX 2.30
- MSGS 5.80
- MACD
- PCVX 0.26
- MSGS -0.72
- Stochastic Oscillator
- PCVX 91.15
- MSGS 37.63
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.